Galaxy Biomedical Investment Co., Ltd.

符号: 000806.SZ

SHZ

0.43

CNY

今天的市场价格

-1.1415
市盈率
0.0445
PEG比率
494.96M
MRK市值
0.00%
DIV收益率

Galaxy Biomedical Investment Co., Ltd. (000806-SZ) 财务报表

Q: 什么是 Galaxy Biomedical Investment Co., Ltd. (000806.SZ) 总资产是多少？

Galaxy Biomedical Investment Co., Ltd. (000806.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Galaxy Biomedical Investment Co., Ltd. (000806.SZ). 的默认数据。公司收入显示 801.805 M 的平均值，即 0.149 % 增长率。整个期间的平均毛利润为 224.165 M，即 0.171 %. 平均毛利率为 0.305 %. 公司去年的净收入增长率为 -0.652 %，等于 -10.411 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Galaxy Biomedical Investment Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.156. 在流动资产领域，000806.SZ 的报告货币为1462.829. 这些资产中的很大一部分，即 81.07 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.041%. 公司的长期投资虽然不是其重点，但以报告货币计算的91.448（如果有的话）为91.448。这表明与上一报告期相比，-48.760% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 9.265. 这一数字表明，0.656% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 -1253.029. 这方面的年同比变化率为 0.415%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为1177.449，存货估值为 199.62，商誉估值为 0（如有. 无形资产总额（如果有）按 112.99 估值. 应付账款和短期债务分别为 285.36 和 189.2. 债务总额为198.47，债务净额为 120.46. 其他流动负债为 569.05，加上总负债 3249.36. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
balance-sheet.row.cash-and-short-term-investments	264.37	81.1	84.6	134.8	100.4	50.7	265.9	470	569.9	312	83	120.5	203.5	347.1	211.2	114.5	146.7	88.5	234.2	336.9	561.3	620.4	165.4	90.5	80.5	40.3	9.6	1.8	1.1	1.6
balance-sheet.row.short-term-investments	12.53	3.1	-64.1	24.8	-53.9	-54.4	0	67.3	0	0	0	0	0	59	0	0	0.6	0	1.3	0	1.6	51.7	0.9	0	34	0	0	0	0	0
balance-sheet.row.net-receivables	4166.94	1177.4	759.4	1146.2	696.1	1414.1	1208.3	725.7	778.2	747.4	689.6	783.9	945.8	1442.6	1747.5	1265.7	1292.5	1140.1	978.8	1060	859.5	564.5	378.5	180.2	54.9	45.3	17.2	11.2	16.6	13.4
balance-sheet.row.inventory	895.34	199.6	280.5	233.4	259.5	230.2	482.7	455.9	390.4	329.3	311.9	252.1	351.1	285.1	319.1	379.9	328.6	399.7	315.2	274.8	249.3	155.8	136.3	63.5	45.9	79.2	51.9	55.7	33.2	38.5
balance-sheet.row.other-current-assets	17.9	4.7	8	5.5	8.8	21	156.4	144.9	70	2.3	0.7	-105.3	0.5	-271.8	-360.8	0.1	0.5	0	0	119.8	-270	0.8	1	159.5	106.6	89.7	52	30.4	25	16
balance-sheet.row.total-current-assets	5344.56	1462.8	1132.4	1519.9	1064.8	1716.1	2113.3	1796.5	1808.4	1390.9	1085.2	1051.1	1500.9	1803	1917	1760.1	1768.3	1628.4	1528.3	1791.5	1400.2	1341.4	681.2	493.6	287.9	254.5	130.6	99	76	69.5
balance-sheet.row.property-plant-equipment-net	1034.32	253.5	285.9	274.1	283	308.8	328.7	377.8	377.4	385.5	412.1	440.5	451.5	456.2	414.7	902.5	1021.6	1383.9	1396.3	974.5	869.1	670.4	398.2	267.5	218.5	192.4	82.1	78.4	68.9	32.2
balance-sheet.row.goodwill	0	0	0	0	0	0	27.3	165.1	189.1	26	26	26	26	26	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	451.89	113	115.9	121.4	125	127.9	157.7	170.2	188.8	212.3	222	232.3	249.8	266	238.6	237	228.1	84.6	94.1	63	62.7	22	14.3	12.8	11.5	5.8	4.8	1.2	1.4	1.5
balance-sheet.row.goodwill-and-intangible-assets	451.89	113	115.9	121.4	125	127.9	185	335.3	377.9	238.3	247.9	258.3	275.8	292	238.6	237	228.1	84.6	94.1	63	62.7	22	14.3	12.8	11.5	5.8	4.8	1.2	1.4	1.5
balance-sheet.row.long-term-investments	376.94	91.4	178.5	96.2	210.6	292.4	329.7	41.1	77.4	103.3	197.3	220.3	168.5	134.7	320.4	0	638.6	0	266.4	0	153.5	75.7	99	0	-20.5	0	0	0	0	0
balance-sheet.row.tax-assets	84.57	19.2	21.3	29.1	25.9	28.3	58.6	40.2	48.7	75.2	79.8	79.5	82.1	74.5	53.8	68.4	63	0	3.3	0	0	58.5	5.2	0	34.3	0	0	0	0	0
balance-sheet.row.other-non-current-assets	282.57	66.6	2.2	85.8	9.7	8.6	677.7	295.7	87.4	114.9	257.9	281	229.2	140.9	381	301.8	48.6	288.6	3.9	223.6	7	72.6	20.2	108.8	67.2	11.1	9	9.4	9.3	9.4
balance-sheet.row.total-non-current-assets	2230.29	543.7	603.8	606.7	654.3	766	1250	1090	891.4	813.8	997.9	1059.3	1038.7	1098.3	1088.2	1509.6	1975.6	1757.1	1760.7	1261.1	1092.4	840.7	531.7	389.1	276.7	209.3	95.9	89	79.6	43.2
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	7574.85	2006.5	1736.2	2126.6	1719.1	2482.1	3363.3	2886.5	2699.8	2204.8	2083.1	2110.4	2539.6	2901.4	3005.2	3269.8	3743.8	3385.5	3289	3052.6	2492.5	2182.2	1212.9	882.7	564.7	463.8	226.5	188	155.6	112.6
balance-sheet.row.account-payables	1094.26	285.4	261	304.1	339.8	265.8	295.2	301	289.7	453.2	271	226.3	260	242.1	193.5	318.6	156.7	216.6	98.9	173.5	165.9	99.5	51.9	17.9	8.8	19	7.7	30.5	19.8	8.4
balance-sheet.row.short-term-debt	628.06	189.2	109.3	99.4	122.2	530.5	229	209	95	628	517.9	497	761.7	725.4	827.2	1065.6	1037	1268.3	1401.8	1062	933.8	688.7	505.7	314	65	46.3	50.7	15	13.3	4.7
balance-sheet.row.tax-payables	167.03	45.5	28.7	20.6	10	11.5	20.9	12.8	16.1	15.9	9.9	7.4	4.1	21.3	22.9	22.8	45.1	5.1	14.6	23.4	17.3	18	20.1	12.7	20.1	15.5	4.6	7.4	3.1	3
balance-sheet.row.long-term-debt-total	37.22	9.3	10.6	59	60	0	380	30	0	64	174	296.5	296.5	542.5	340.1	290.2	355.6	421.3	221.7	238.5	201.7	117.1	91.3	92.6	111.6	66.6	0	0	0	0
Deferred Revenue Non Current	151.14	36.3	41.2	44.4	52.4	52.6	58.6	56	57.2	55.7	1.5	1.5	2.8	23.6	88.7	36.4	36.5	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	17.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	2038.13	569	18.1	310.2	460.8	228.8	213.2	178.1	189.9	151.7	183.4	144.3	306	226	296.7	402.4	504.1	339.6	257.3	237.7	-94.2	141.4	102.2	68.5	60.5	30.3	14.2	27.7	40.4	25.6
balance-sheet.row.total-non-current-liabilities	8221.88	2205.7	1830.1	924.8	485.5	55	449.2	86.6	57.3	129.1	249	377	379	659.9	478.5	362.9	469.9	463.6	266.5	281.6	244.1	158.6	100.1	101.5	120.8	82.2	0	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	36.02	8.7	10.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	11982.32	3249.4	2631.1	2063.9	1701.1	1091.5	1186.6	774.6	631.9	1362	1221.3	1244.5	1706.6	1853.5	1795.9	2149.5	2167.8	2288.1	2024.5	1754.9	1249.6	1088.2	759.9	501.8	255.1	177.8	72.6	73.2	73.5	38.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	4399.65	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	699.2	699.2	699.2	699.2	699.2	699.2	699.2	635.6	635.6	418.7	349	303.4	303.4	211.6	211.6	162.8	82.2	61.2	61.2	61.2	61.2
balance-sheet.row.retained-earnings	-13566.1	-3534.5	-3175	-2195.6	-2253.9	-908.3	-202.7	-212.3	-225.2	-327.7	-353.8	-366	-390.1	-211.7	-137.5	-177.5	27.3	-34.6	158.2	158.9	208.2	133.2	113.8	58	53.5	65.1	40.4	18	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	4719.39	1181.5	1189.5	1162.6	1178.1	1194.3	1208.7	1146.1	1138.1	447.5	490	506.4	499.3	525.7	611.1	560.6	859.2	461.8	663.1	768.4	713	643.2	119.1	102	83.9	129.4	27.8	23.8	12.9	5
balance-sheet.row.total-stockholders-equity	-4447.07	-1253	-885.6	66.9	24.1	1385.9	2105.9	2033.8	2012.8	819	835.5	839.7	808.5	1013.2	1172.7	1082.3	1522.1	1062.8	1240	1276.3	1224.6	1079.8	444.5	371.6	300.2	276.7	129.4	103	74.1	66.2
balance-sheet.row.total-liabilities-and-stockholders-equity	7574.85	2006.5	1736.2	2126.6	1719.1	2482.1	3363.3	2886.5	2699.8	2204.8	2083.1	2110.4	2539.6	2901.4	3005.2	3269.8	3743.8	3385.5	3289	3052.6	2492.5	2182.2	1212.9	882.7	564.7	463.8	226.5	188	157.6	112.6
balance-sheet.row.minority-interest	39.6	10.2	-9.3	-4.2	-6.1	4.7	70.8	78.1	55.1	23.8	26.3	26.2	24.5	34.7	36.5	37.9	53.9	34.6	24.4	21.4	18.3	14.1	8.6	9.4	9.4	9.3	24.6	11.8	9.9	7.8
balance-sheet.row.total-equity	-4407.47	-1242.8	-894.9	62.7	18	1390.6	2176.7	2111.9	2067.9	842.8	861.8	865.9	832.9	1047.9	1209.3	1120.2	1576.1	1097.4	1264.4	1297.7	1242.9	1094	453	381	309.6	286	154	114.8	84	73.9
balance-sheet.row.total-liabilities-and-total-equity	7574.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	389.47	94.5	114.4	121	156.7	238	208.9	108.4	74	101.7	196.5	219.4	163.5	193.7	295.1	275.6	639.2	286.7	267.7	219.8	155.1	127.5	99.9	87.1	13.5	9.1	0	0	0	0
balance-sheet.row.total-debt	665.27	198.5	119.9	158.4	182.2	530.5	609	239	95	692	691.9	793.5	1058.2	1267.9	1167.3	1355.8	1392.6	1689.6	1623.5	1300.5	1135.5	805.8	597	406.6	176.6	112.8	50.7	15	13.3	4.7
balance-sheet.row.net-debt	413.43	120.5	35.3	48.4	81.8	479.8	343.1	-163.8	-474.9	380	608.8	673	854.7	979.8	956	1241.3	1246.5	1601	1390.6	963.6	575.8	237.1	432.5	316.1	130	72.5	41.1	13.2	12.2	3.1

现金流量表

在 Galaxy Biomedical Investment Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.169 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 0. 公司的投资活动产生了现金使用净额，按报告货币计算达到6923402.000. 与上一年相比， -0.518 发生了变化. 在同一时期，公司记录了 46.94, 1.33 和 -80.9，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-4.71 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 103.99，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	-395.78	-336.6	-968.5	62.1	-1169.5	-736.3	14.6	16.4	102.6	23	12.4	25.9	-187.6	-57.6	51.4	-185.6	26.2	-180.9	10.2	143.2	127.4	79	93.4	89	49.2	30.7
cash-flows.row.depreciation-and-amortization	0	46.9	47.4	28.2	32.1	44.3	42.7	42.2	57.5	46.7	46.6	46.5	49.2	47.8	45.6	85.8	100.8	87.5	86.6	62.4	33.3	27.8	18.8	18.6	15.7	5.3
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	0	-229.6	-94.8	-74.1	345.8	-140.5	-124.9	15.8	-140.4	-11.2	-8.4	250.8	214	142.8	-286.7	-228.9	-73.6	-127.6	-197.2	-319.4	1.6	-71.3	-69.8	-84.7	-76.6	-39.7
cash-flows.row.account-receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	0	80.9	-47.7	26.7	-22.1	89.4	-24.1	-65.5	-61.1	-17.4	-59.8	99	-66	37.1	60.8	-52.2	72.7	-97.6	-42.6	-25.4	-93.6	31	-72.9	-17.6	-6.8	-20.4
cash-flows.row.account-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-310.5	-47.1	-100.8	367.9	-229.9	-100.8	81.3	-79.3	6.2	51.4	151.8	280	105.7	-347.5	-176.7	-146.3	-30.1	-154.6	-294	95.1	-102.3	3	-67.1	-69.9	-19.3
cash-flows.row.other-non-cash-items	0	485.3	988.5	28.5	854.9	468.2	0.5	12	-117.4	-9.2	13.4	-19.9	181.3	118.5	-5	297.9	128.2	174.5	122.1	39.2	14.3	28.2	20.5	10	1	6.1
cash-flows.row.net-cash-provided-by-operating-activities	-395.78	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-6.2	-7	-22.1	-18.6	-11.4	-13.9	-65.2	-38.5	-20	-9.3	-8.4	-23.3	-59.9	-124.3	-126.4	-18.4	-15.9	-112.5	-104.6	-181.7	-251.4	-253.8	-96.9	-169.2	-16	-98
cash-flows.row.acquisitions-net	0	0	0.8	19.6	19.2	97.5	0.7	0.4	-166	0	0	0	11.1	0.9	396.4	27.9	0	8.5	0	181.8	264.6	3.3	0.2	0	16	99.8
cash-flows.row.purchases-of-investments	-26.43	-64.7	-282.3	-220.1	-170.1	-263.8	-1142.3	-570.9	-216.9	-3	0	-65	-0.5	-105.6	-10	-13	-7.1	-0.8	-79.1	-74.8	-151.6	-145.8	-58.3	-76.2	-55.5	-2.1
cash-flows.row.sales-maturities-of-investments	33.27	77.2	315.6	212.9	202.8	372.6	795.7	199.2	285.7	138.6	63.5	23.3	118.2	22.8	243.4	95.4	142	2.3	6.9	14	194.5	56.1	3.2	52.7	30.9	5.1
cash-flows.row.other-investing-activites	1.31	1.3	2.2	-18.6	1.5	13.6	31.7	6.4	43.5	-9.2	15	15.4	14.3	69.1	26.3	15.1	127.5	15.1	3.1	0	13.2	3	0.3	2.7	0	1.8
cash-flows.row.net-cash-used-for-investing-activites	1.96	6.9	14.4	-24.8	41.9	205.9	-380.1	-403.8	-73.7	117.1	70.1	-49.6	72.1	-137.1	529.7	107.1	246.5	-95.9	-173.8	-242.5	-195.3	-340.6	-151.8	-190	-40.5	-93.2
cash-flows.row.debt-repayment	-76.39	-80.9	-25	-26	-131.9	-162	-424	-105	-708	-736.8	-585.8	-873.3	-998.2	-1145.8	-884.4	-419.5	-764.9	-1233.1	-1539	-847.2	-848.7	-648.8	-379.5	-111	-44.8	-117.8
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-13.53	-4.7	-4.8	-8	-17	-35.1	-15.2	-7.1	-17.6	-50.1	-52.4	-73.2	-110.4	-170.2	-112.8	-64.6	-58.6	-101.1	-86.4	-70.7	-49.9	-43.5	-48.9	-25.5	-7.2	-16.4
cash-flows.row.other-financing-activites	129.27	104	19.7	21.6	77.6	159.5	763.7	260.7	1250.7	732.8	481.4	605.6	762.4	1216.8	713	376.2	452.7	1332.3	1673.4	1012.2	908.4	1373.3	577.8	337.3	111.8	251.5
cash-flows.row.net-cash-used-provided-by-financing-activities	39.35	18.4	-10.1	-12.4	-71.3	-37.6	324.5	148.5	525.2	-54.1	-156.8	-340.9	-346.1	-99.2	-284.2	-108	-370.8	-1.9	48.1	94.4	9.8	681	149.3	200.9	59.8	117.4
cash-flows.row.effect-of-forex-changes-on-cash	36.36	0.3	-0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5
cash-flows.row.net-change-in-cash	2.85	-8.4	-23	7.5	33.9	-195.9	-122.6	-168.9	353.8	112.5	-22.7	-87.3	-17.2	15.3	50.8	-31.6	57.2	-144.3	-104	-222.8	-8.9	404.1	60.4	43.9	8.5	26.9
cash-flows.row.cash-at-end-of-period	114.55	42.2	50.6	73.6	66.1	32.2	228.1	350.7	519.7	165.9	53.4	76.1	163.4	180.6	165.3	114.5	146.1	88.5	232.9	336.9	559.7	568.6	165.4	90.5	46.6	40.3
cash-flows.row.cash-at-beginning-of-period	111.7	50.6	73.6	66.1	32.2	228.1	350.7	519.7	165.9	53.4	76.1	163.4	180.6	165.3	114.5	146.1	88.9	232.9	336.9	559.7	568.6	164.5	105	46.6	38	13.4
cash-flows.row.operating-cash-flow	-395.78	-34	-27.3	44.7	63.2	-364.3	-67.1	86.4	-97.7	49.4	64	303.3	256.9	251.6	-194.7	-30.7	181.5	-46.6	21.7	-74.7	176.6	63.6	62.8	33	-10.7	2.3
cash-flows.row.capital-expenditure	-6.2	-7	-22.1	-18.6	-11.4	-13.9	-65.2	-38.5	-20	-9.3	-8.4	-23.3	-59.9	-124.3	-126.4	-18.4	-15.9	-112.5	-104.6	-181.7	-251.4	-253.8	-96.9	-169.2	-16	-98
cash-flows.row.free-cash-flow	-401.98	-41	-49.3	26.1	51.8	-378.3	-132.3	47.9	-117.6	40.1	55.6	279.9	197	127.3	-321.1	-49.1	165.6	-159.1	-82.9	-256.4	-74.8	-190.1	-34.1	-136.2	-26.7	-95.7

利润表行

Galaxy Biomedical Investment Co., Ltd. 的收入与上期相比变化了 0.336%。据报告, 000806.SZ 的毛利润为 542.64。该公司的营业费用为 298.37，与上年相比变化了 -11.742%. 折旧和摊销费用为 46.94，与上一会计期间相比变化了 -0.011%. 营业费用报告为 298.37，显示-11.742% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长2.650%. 营业收入为 218.64，与上年相比变化了2.650%. 净利润的变化率为 -0.652%。去年的净收入为-336.6.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
income-statement-row.row.total-revenue	1452.29	1528	1144.1	1106	781.4	761.3	1045.7	1204.6	832.4	801.9	784.1	957.3	957.6	976.7	1019.3	1754.9	1750.4	1015.2	987.8	1008.2	784.5	631.1	401.1	283.8	165.2	148.1	133	125.1	102.3	61.3
income-statement-row.row.cost-of-revenue	944.86	985.4	718.3	720.8	566.8	603.9	756.2	889.3	610.7	587.1	563.5	736.5	817.9	740.1	743.5	1320	1314.5	815.5	691.9	748.1	554.8	448.5	224.2	141.1	96.9	95.8	75.3	78	67.4	39.6
income-statement-row.row.gross-profit	507.44	542.6	425.8	385.2	214.6	157.3	289.5	315.3	221.7	214.8	220.6	220.8	139.7	236.6	275.9	434.9	435.9	199.8	295.9	260.1	229.7	182.6	176.9	142.8	68.3	52.3	57.6	47.2	34.9	21.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	73.39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	39.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	92.94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	100.99	101.3	94.5	41.9	90.8	-3.2	5.9	12.4	42.4	-2.3	3.6	12.1	9.9	21.1	3.8	6.5	5.3	-3.3	9.5	-4.8	6.6	8.2	2.4	2.3	16.1	8.2	0	4.2	3.8	3.6
income-statement-row.row.operating-expenses	306.42	298.4	338.1	201.8	320.7	390.5	288	282.8	246.3	189.9	188.2	212.7	232.7	210	207.4	305.1	271.9	240.8	218.9	188.1	121.2	87.9	60.2	44.3	22.8	20	8.8	6.4	3.8	5
income-statement-row.row.cost-and-expenses	1251.28	1283.7	1056.4	922.6	887.6	994.5	1044.2	1172.1	856.9	777	751.7	949.3	1050.6	950.1	950.9	1625.1	1586.4	1056.3	910.8	188.1	676	536.4	284.3	185.4	119.7	115.8	84.2	84.3	71.1	44.6
income-statement-row.row.interest-income	0.22	0.2	0.3	0.2	0.2	0.3	2.1	4.3	5.7	0.9	0.4	1.3	1.5	1.4	0	0.6	1.4	6	3.9	18.4	5.4	9.5	1.3	2.7	0	0	0	0	0	0
income-statement-row.row.interest-expense	20.59	18.9	14.5	20.2	64.2	64.8	14.9	9.2	17.6	57	52.1	73.6	76.2	91.9	105	138.4	108.8	89.7	81.3	53.8	49.5	32.3	22.4	11	3.6	3.3	2.7	1.5	0.9	0.8
income-statement-row.row.selling-and-marketing-expenses	92.94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-162.12	-521.4	-992.9	-26.5	-1265.4	-468.3	5.9	12	40.8	-2.6	3.5	12	9.9	20.4	-25.4	-57.4	-8.8	-10.2	2.4	2.3	2.2	3.1	1.8	1.8	11.4	8.7	-0.1	0	-0.1	-0.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	100.99	101.3	94.5	41.9	90.8	-3.2	5.9	12.4	42.4	-2.3	3.6	12.1	9.9	21.1	3.8	6.5	5.3	-3.3	9.5	-4.8	6.6	8.2	2.4	2.3	16.1	8.2	0	4.2	3.8	3.6
income-statement-row.row.total-operating-expenses	-162.12	-521.4	-992.9	-26.5	-1265.4	-468.3	5.9	12	40.8	-2.6	3.5	12	9.9	20.4	-25.4	-57.4	-8.8	-10.2	2.4	2.3	2.2	3.1	1.8	1.8	11.4	8.7	-0.1	0	-0.1	-0.1
income-statement-row.row.interest-expense	20.59	18.9	14.5	20.2	64.2	64.8	14.9	9.2	17.6	57	52.1	73.6	76.2	91.9	105	138.4	108.8	89.7	81.3	53.8	49.5	32.3	22.4	11	3.6	3.3	2.7	1.5	0.9	0.8
income-statement-row.row.depreciation-and-amortization	385	46.9	47.4	28.2	-210.7	44.3	42.7	42.2	57.5	46.7	46.6	46.5	49.2	47.8	45.6	85.8	100.8	87.5	86.6	62.4	33.3	27.8	18.8	18.6	15.7	5.3	2.7	-7	-7.2	-6.2
income-statement-row.row.ebitda-caps	178.88	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-206.12	218.6	59.9	109.7	-106.2	-702.8	4.1	24.4	97.3	35.8	18	22.5	-201	-104.3	100.6	-110	46.8	-160.8	12.2	109.3	109.3	78.6	98.8	92.7	50.2	31.4	46.1	47.8	38.4	22.9
income-statement-row.row.income-before-tax	-368.24	-302.7	-933	83.2	-1371.5	-701.5	10.1	36.4	138.1	33.2	21.5	34.5	-191.1	-83.9	75.2	-167.4	38	-171	14.6	111.6	111.5	81.7	100.7	94.5	61.6	40.2	46.1	47.8	38.3	22.9
income-statement-row.row.income-tax-expense	27.05	33.9	35.5	21.1	11.3	39.3	-3.9	19.9	35.5	10.2	9.1	8.7	-3.6	-12.1	29.9	18.2	11.8	9.9	10.4	9.1	17.3	12.9	7.3	5.5	12.3	9.5	6.9	7.2	3	3
income-statement-row.row.net-income	-395.78	-336.6	-968.5	58.3	-1382.8	-706	10.2	12.9	102.5	26.1	12.2	24.1	-178.4	-74.1	39.9	-198.4	11.7	-183.4	0.9	7.1	90.1	66.8	92.5	87.6	48.3	29	26.4	28.9	26.3	18.4